Illinois Municipal Retirement Fund Trims Stake in Humana Inc. (NYSE:HUM)

Illinois Municipal Retirement Fund trimmed its position in Humana Inc. (NYSE:HUM - Free Report) by 29.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 24,579 shares of the insurance provider's stock after selling 10,030 shares during the period. Illinois Municipal Retirement Fund's holdings in Humana were worth $11,253,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of HUM. Mariner LLC lifted its position in shares of Humana by 2.3% during the 3rd quarter. Mariner LLC now owns 14,119 shares of the insurance provider's stock valued at $6,869,000 after buying an additional 312 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Humana by 27.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider's stock valued at $13,595,000 after buying an additional 6,034 shares in the last quarter. Silverarc Capital Management LLC purchased a new position in shares of Humana during the 3rd quarter valued at about $4,865,000. Vest Financial LLC lifted its position in shares of Humana by 43.3% during the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider's stock valued at $12,815,000 after buying an additional 8,455 shares in the last quarter. Finally, Artemis Investment Management LLP lifted its position in shares of Humana by 9.6% during the 4th quarter. Artemis Investment Management LLP now owns 64,573 shares of the insurance provider's stock valued at $29,563,000 after buying an additional 5,672 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Jorge S. Mesquita bought 545 shares of the stock in a transaction on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the acquisition, the director now owns 2,578 shares of the company's stock, valued at $946,358.02. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.29% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on HUM. The Goldman Sachs Group decreased their target price on Humana from $450.00 to $385.00 and set a "buy" rating on the stock in a research note on Wednesday, April 3rd. Royal Bank of Canada decreased their target price on Humana from $507.00 to $415.00 and set an "outperform" rating on the stock in a research note on Friday, January 26th. Truist Financial reissued a "hold" rating and set a $550.00 target price on shares of Humana in a research note on Friday, January 19th. Raymond James began coverage on Humana in a research note on Friday, March 22nd. They set a "market perform" rating on the stock. Finally, UBS Group reissued a "neutral" rating and set a $370.00 target price (down previously from $530.00) on shares of Humana in a research note on Friday, January 26th. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $454.63.

Humana Trading Up 0.8 %

Shares of NYSE HUM traded up $2.54 during trading hours on Tuesday, hitting $327.84. 1,613,408 shares of the company traded hands, compared to its average volume of 1,984,984. The stock has a market capitalization of $39.55 billion, a price-to-earnings ratio of 16.44, a price-to-earnings-growth ratio of 1.92 and a beta of 0.45. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The company's 50 day moving average price is $330.09 and its 200 day moving average price is $399.70. Humana Inc. has a 12 month low of $299.23 and a 12 month high of $541.21.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The business had revenue of $26.46 billion for the quarter, compared to analysts' expectations of $25.47 billion. During the same quarter in the previous year, the firm earned $1.62 EPS. Humana's revenue was up 17.9% compared to the same quarter last year. On average, equities research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.08%. The ex-dividend date is Friday, June 28th. Humana's dividend payout ratio is 17.86%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.